AOD-9604 Co

Editorial archive: these generated medical guides remain available while each source and claim is reviewed. This hub and its guides are not approved for indexing or AI citation.

ComparisonsAOD-9604 vs clenbuterol: what the human data actually showsAOD-9604's own obesity trials didn't beat placebo convincingly. Clenbuterol has real fat-burning data too, but from livestock and vets, not people. Neither is clean.Updated 2026-07-25Read guideComparisonsAOD-9604 vs HGH fragment: are they the same thing?AOD-9604 is HGH fragment 176-191, same molecule, same name. Here's what the human obesity trials actually showed, and why the results didn't beat placebo.Updated 2026-07-25Read guideComparisonsAOD-9604 vs semaglutide: what the human trial data actually showsAOD-9604's obesity trials didn't beat placebo convincingly. Semaglutide's did, with 15%+ body weight loss in trials. Here's the honest comparison.Updated 2026-07-25Read guideComparisonsAOD-9604 vs tesamorelin: what the human trial data actually showsAOD-9604's obesity trials didn't beat placebo convincingly. Tesamorelin has FDA approval for a specific use. Here's the honest comparison, dose by dose.Updated 2026-07-25Read guideComparisonsAOD-9604 vs tirzepatide: what the evidence actually saysAOD-9604's obesity trials never beat placebo convincingly. Tirzepatide cut body weight over 20% in trials. Here's the honest head-to-head comparison.Updated 2026-07-25Read guideComparisonsAOD-9604 vs ipamorelin: what the human trial data actually showsAOD-9604's own obesity trials didn't beat placebo convincingly. Ipamorelin has different, GH-driven evidence. Here's the honest head-to-head comparison.Updated 2026-07-24Read guideComparisonsAOD-9604 vs MOTS-c: which one actually has data behind itAOD-9604's obesity trials didn't beat placebo. MOTS-c has mitochondrial data in mice, not humans. Neither is a proven fat-loss drug. Full comparison here.Updated 2026-07-24Read guide
Start provider review